Sfoglia per Rivista
Comorbidities influence compliance and developement of pleural effusions in elderly chronic myeloid leukemia (CML) patients treated with dasatinib.
2009-01-01 Breccia M.; Latagliata R.; Stagno F.; Luciano L.; Gozzini A.; Annunziata M.; De Matteis S.; Albano F.; Rege-Cambrin G.; Pregno P.; Pacilli M.; Abruzzese E.; Martino B.; Tiribelli M.; Russo Rossi A.; Specchia G.; Sica S.; Vitolo U.; Montefusco E.; Fava C.; Ferrara F.; Santini V.; Pane F.; Di Raimondo F.; Alimena G.
Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis.
2003-01-01 A. PIGA; C. GAGLIOTI; E. FOGLIACCO; F. TRICTA
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation
2020-01-01 Lorentino, Francesca; Sacchi, Nicoletta; Oldani, Elena; Miotti, Valeria; Picardi, Alessandra; Gallina, Anna Maria; Crivello, Pietro; Bernasconi, Paolo; Saccardi, Riccardo; Farina, Lucia; Benedetti, Fabio; Cerno, Michela; Grassi, Anna; Bruno, Benedetto; Patriarca, Francesca; Ciceri, Fabio; Fleischhauer, Katharina; Vago, Luca; Bonifazi, Francesca
Comparison between ABVD + radiotherapy and MOPP + radiotherapy in Hodgkin's disease stage II and III [CONFRONTO FRA ABVD + RADIOTERAPIA E MOPP + RADIOTERAPIA NEL MORBO DI HODGKIN IN STADIO II E III]
1994-01-01 Ficara; F.; Levis; A.; Bertini; M.; Ricardi; U.; Vitolo; U.; Resegotti; L.
COMPARISON OF DIFFERENT RQ-PCR DESIGN STRATEGIES FOR MINIMAL RESIDUAL DISEASE DETECTION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND RQ-PCR PERFORMANCE
2013-01-01 Della Starza I.; Cavalli M.; Del Giudice I.; Monitillo L
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4
2015-01-01 Fava, C; Gottardi, E; Berchialla, P; Rege-Cambrin, G; Varotto, M; Daraio, F; Crasto, F; Lorenzatti, R; Volpengo, A; Fantino, C; Dani, N; Barberio, D; Dogliotti, I; Saglio, G
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: a multicentric italian survey
2012-01-01 D'Arena G; Laurenti L; Del Poeta G; Grossi A; Coscia M; Mometto G; Chiarenza A; Selleri C; Vigliotti ML; Pozzato G; Nunziata G; La Sala A; Villa MR; Simeon V; Deaglio S; De Feo V; Musto P
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment.
1990-01-01 Tarella C; Ferrero D; Siena S; Gallo E; Bondesan P; Bregni M; Pileri A; Gianni AM.
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment.
1990-01-01 TARELLA C ;FERRERO D ;SIENA S ;GALLO E ;BONDESAN P ;BREGNI M ;PILERI A ;GIANNI AM
Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy.
1990-01-01 PALUMBO AP ;GARINO AL ;FRIERI R ;GALLONE G ;BOCCADORO M ;PILERI A
Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment
2004-01-01 G. SAGLIO; D. CILLONI
Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional study
2005-01-01 PALUMBO A; PETRUCCI MT; LAUTA VM; MUSTO P; CARAVITA T; BARBUI AM; NUNZI M; M. BOCCADORO; ITALIAN MULTIPLE MYELOMA STUDY GROUP
Corticosteroids can reverse severe imatinib-induced hepatotoxicity
2006-01-01 FERRERO D; POGLIANI EM; REGE-CAMBRIN G; FAVA C; MATTIOLI G; DELLACASA C; CAMPA E; PERFETTI P; FUMAGALLI M; BOCCADORO M
A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
2015-01-01 Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G
Cumulative analysis of post induction WT1 values and WT1 onset/post induction ratio as an udeful tool for a risk stratification of acute myeloid leukemia patients
2015-01-01 Coluzzi, S.; Introcaso, T.; Iallorenzi, P.; Di Nardo, E.; Pascale, Sp.; Nuccorini, R.; Attolico, I.; Matturro, A.; Amendola, A.; Cimminiello, M.; Vertone, D.; Filardi, N.; Pizzuti, M.
Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms
2014-01-01 T. I. Mughal;A. M. Vannucchi;S. Soverini;A. Bazeos;R. Tibes;G. Saglio;O. Abdel-Wahab;A. Pardanani;R. Hehlmann;T. Barbui;R. Van Etten;A. Tefferi;J. M. Goldman
Current role and future developments of radiotherapy in Hodgkin's lymphoma.
2011-01-01 Ricardi U; Filippi AR
Current therapeutic options for multiple myeloma.
1996-01-01 Pileri A; Palumbo A; Boccadoro M
Current therapeutic options for multiple myeloma.
1996-01-01 PILERI A ;PALUMBO A ;BOCCADORO M
Cyclic neutropenia and severe hypogammaglobulinemia in a patient with excess of CD8-positive T lymphocytes: response to G-CSF therapy.
1993-01-01 FERRERO D ;PREGNO P ;OMEDÈ P ;DIANZANI U ;CARBONE A ;DI CELLE PF ;GALLO E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comorbidities influence compliance and developement of pleural effusions in elderly chronic myeloid leukemia (CML) patients treated with dasatinib. | 2009 | Breccia M.; Latagliata R.; Stagno F.; Luciano L.; Gozzini A.; Annunziata M.; De Matteis S.; Albano F.; Rege-Cambrin G.; Pregno P.; Pacilli M.; Abruzzese E.; Martino B.; Tiribelli M.; Russo Rossi A.; Specchia G.; Sica S.; Vitolo U.; Montefusco E.; Fava C.; Ferrara F.; Santini V.; Pane F.; Di Raimondo F.; Alimena G. | |
| Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. | 2003 | A. PIGA; C. GAGLIOTI; E. FOGLIACCO; F. TRICTA | |
| Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation | 2020 | Lorentino, Francesca; Sacchi, Nicoletta; Oldani, Elena; Miotti, Valeria; Picardi, Alessandra; Gallina, Anna Maria; Crivello, Pietro; Bernasconi, Paolo; Saccardi, Riccardo; Farina, Lucia; Benedetti, Fabio; Cerno, Michela; Grassi, Anna; Bruno, Benedetto; Patriarca, Francesca; Ciceri, Fabio; Fleischhauer, Katharina; Vago, Luca; Bonifazi, Francesca | |
| Comparison between ABVD + radiotherapy and MOPP + radiotherapy in Hodgkin's disease stage II and III [CONFRONTO FRA ABVD + RADIOTERAPIA E MOPP + RADIOTERAPIA NEL MORBO DI HODGKIN IN STADIO II E III] | 1994 | Ficara; F.; Levis; A.; Bertini; M.; Ricardi; U.; Vitolo; U.; Resegotti; L. | |
| COMPARISON OF DIFFERENT RQ-PCR DESIGN STRATEGIES FOR MINIMAL RESIDUAL DISEASE DETECTION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND RQ-PCR PERFORMANCE | 2013 | Della Starza I.; Cavalli M.; Del Giudice I.; Monitillo L | |
| COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 | 2015 | Fava, C; Gottardi, E; Berchialla, P; Rege-Cambrin, G; Varotto, M; Daraio, F; Crasto, F; Lorenzatti, R; Volpengo, A; Fantino, C; Dani, N; Barberio, D; Dogliotti, I; Saglio, G | |
| Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: a multicentric italian survey | 2012 | D'Arena G; Laurenti L; Del Poeta G; Grossi A; Coscia M; Mometto G; Chiarenza A; Selleri C; Vigliotti ML; Pozzato G; Nunziata G; La Sala A; Villa MR; Simeon V; Deaglio S; De Feo V; Musto P | |
| Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment. | 1990 | Tarella C; Ferrero D; Siena S; Gallo E; Bondesan P; Bregni M; Pileri A; Gianni AM. | |
| Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment. | 1990 | TARELLA C ;FERRERO D ;SIENA S ;GALLO E ;BONDESAN P ;BREGNI M ;PILERI A ;GIANNI AM | |
| Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy. | 1990 | PALUMBO AP ;GARINO AL ;FRIERI R ;GALLONE G ;BOCCADORO M ;PILERI A | |
| Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment | 2004 | G. SAGLIO; D. CILLONI | |
| Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional study | 2005 | PALUMBO A; PETRUCCI MT; LAUTA VM; MUSTO P; CARAVITA T; BARBUI AM; NUNZI M; M. BOCCADORO; ITALIAN MULTIPLE MYELOMA STUDY GROUP | |
| Corticosteroids can reverse severe imatinib-induced hepatotoxicity | 2006 | FERRERO D; POGLIANI EM; REGE-CAMBRIN G; FAVA C; MATTIOLI G; DELLACASA C; CAMPA E; PERFETTI P; FUMAGALLI M; BOCCADORO M | |
| A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS | 2015 | Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G | |
| Cumulative analysis of post induction WT1 values and WT1 onset/post induction ratio as an udeful tool for a risk stratification of acute myeloid leukemia patients | 2015 | Coluzzi, S.; Introcaso, T.; Iallorenzi, P.; Di Nardo, E.; Pascale, Sp.; Nuccorini, R.; Attolico, I.; Matturro, A.; Amendola, A.; Cimminiello, M.; Vertone, D.; Filardi, N.; Pizzuti, M. | |
| Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms | 2014 | T. I. Mughal;A. M. Vannucchi;S. Soverini;A. Bazeos;R. Tibes;G. Saglio;O. Abdel-Wahab;A. Pardanani;R. Hehlmann;T. Barbui;R. Van Etten;A. Tefferi;J. M. Goldman | |
| Current role and future developments of radiotherapy in Hodgkin's lymphoma. | 2011 | Ricardi U; Filippi AR | |
| Current therapeutic options for multiple myeloma. | 1996 | Pileri A; Palumbo A; Boccadoro M | |
| Current therapeutic options for multiple myeloma. | 1996 | PILERI A ;PALUMBO A ;BOCCADORO M | |
| Cyclic neutropenia and severe hypogammaglobulinemia in a patient with excess of CD8-positive T lymphocytes: response to G-CSF therapy. | 1993 | FERRERO D ;PREGNO P ;OMEDÈ P ;DIANZANI U ;CARBONE A ;DI CELLE PF ;GALLO E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile